HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday 7 July 2011

Latest journal articles from HEDS

The following articles were published by researchers within HEDS in June (plus a few stragglers from earlier in the year).

Putting a value on the avoidance of false positive results when screening for inherited metabolic disease in the newborn.
Dixon S, Shackley P, Bonham J, Ibbotson R
J Inherit Metab Dis 27 May 2011 DOI

Interhospital variation in the RATPAC Trial (Randomised Assessment of Treatment using Panel Assay of Cardiac markers).
Bradburn M, Goodacre SW, Fitzgerald P, Coats T, Gray A, Hassan T, Humphrey J, Kendall J, Smith J, Collinson P, On behalf of the RATPAC Research Team
Emerg Med J 26 May 2011 DOI

Using Health State Utility Values from the General Population to Approximate Baselines in Decision Analytic Models when Condition-Specific Data are Not Available.
Ara R, Brazier JE
Value Health 14(4):539-545 Jun 2011 DOI

Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in breast cancer in the United kingdom.
Whyte S, Cooper KL, Stevenson MD, Madan J, Akehurst R
Value Health 14(4):465-474 Jun 2011 DOI

Imatinib as adjuvant therapy for gastrointestinal stromal tumors: a systematic review.
Essat M, Cooper K
Int J Cancer 128(9):2202-2214 01 May 2011 DOI

Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel Assay of cardiac markers (RATPAC) trial.
Fitzgerald P, Goodacre SW, Cross E, Dixon S
Acad Emerg Med 18(5):488-495 May 2011 DOI

The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department.
Goodacre S, Bradburn M, Fitzgerald P, Cross E, Collinson P, Gray A, Hall A
Health Technol Assess 15(23):1-108 May 2011 DOI

Cost-Effectiveness of Combination Nonbiologic Disease-Modifying Antirheumatic Drug Strategies in Patients with Early Rheumatoid Arthritis
Tosh JC, Wailoo AJ, Scott DL, Deighton CM
The Journal of Rheumatology 2011

Health utility and survival after hospital admission with acute cardiogenic pulmonary oedema
Goodacre S, Gray A, Newby D, Dixon S, Masson M, Sampson F, Nicholl J, Elliot M, Crane S
Emergency Medicine Journal 28(6):477-482 2011